Keywords: PPC; pulmonary pleomorphic carcinoma; CT; computed tomography; VEGF; vascular endothelial growth factor; EGFR; epidermal growth factor receptor; pulmonary pleomorphic carcinoma,; chemotherapy,; bevacizumab,; vascular endothelial growth factor;